HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy.

Abstract
The authors recently observed a boy with bilateral choroidal neovascularization associated with Best's disease and compared the outcome of photodynamic therapy in one eye with the natural history of the untreated fellow eye. The final outcome of photodynamic therapy was inactive choroidal neovascularization, which seemed to be enveloped by the retinal pigment epithelium. The final appearance of the treated lesion was similar to the natural evolution of choroidal neovascularization in the untreated fellow eye.
AuthorsFrancesco Viola, Edoardo Villani, Chiara Mapelli, Giovanni Staurenghi, Roberto Ratiglia
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) 2010 Mar-Apr Vol. 47 Issue 2 Pg. 121-2 ISSN: 0191-3913 [Print] United States
PMID20349908 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright (c) 2010, SLACK Incorporated.
Chemical References
  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin
Topics
  • Child
  • Choroidal Neovascularization (diagnosis, etiology, therapy)
  • Corneal Dystrophies, Hereditary (complications, diagnosis)
  • Diagnosis, Differential
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Macula Lutea (pathology)
  • Male
  • Photochemotherapy (methods)
  • Photosensitizing Agents (therapeutic use)
  • Porphyrins (therapeutic use)
  • Verteporfin
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: